Summit Rock Advisors, LP - Q4 2020 holdings

$287 Million is the total value of Summit Rock Advisors, LP's 10 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 180.0% .

 Value Shares↓ Weighting
VT NewVANGUARD INTL EQUITY INDEX Ftt wrld st etf$102,246,0001,104,408
+100.0%
35.66%
VSS NewVANGUARD INTL EQUITY INDEX Fftse smcap etf$59,429,000487,765
+100.0%
20.72%
IUSV SellISHARES TRcore s&p us vlu$45,175,000
-51.2%
726,403
-57.4%
15.75%
-63.2%
HYG BuyISHARES TRiboxx hi yd etf$36,181,000
+37.2%
414,440
+31.8%
12.62%
+3.4%
ICVT NewISHARES TRconv bd etf$16,631,000172,253
+100.0%
5.80%
EDV NewVANGUARD WORLD FDextended dur$14,891,00097,773
+100.0%
5.19%
BKLN NewINVESCO EXCH TRADED FD TR IIsr ln etf$10,409,000467,191
+100.0%
3.63%
PHAT SellPHATHOM PHARMACEUTICALS INC$1,141,000
-10.5%
34,350
-1.2%
0.40%
-32.5%
AKRO NewAKERO THERAPEUTICS INC$384,00014,891
+100.0%
0.13%
GBIO NewGENERATION BIO CO$258,0009,113
+100.0%
0.09%
GOVT ExitISHARES TRus treas bd etf$0-497,312
-100.0%
-6.43%
ACWI ExitISHARES TRmsci acwi etf$0-1,025,149
-100.0%
-37.91%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-02-12
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ISHARES TR29Q3 202090.6%
ISHARES TR26Q4 202051.7%
ISHARES INC11Q1 202064.0%
ISHARES TR11Q4 202147.6%
ISHARES TR9Q2 201534.5%
PHATHOM PHARMACEUTICALS INC9Q2 20221.1%
ISHARES TR RUS 2000 VAL ETF7Q4 202247.0%
SELECT SECTOR SPDR TR ENERGY6Q3 202367.4%
VANGUARD INTL EQUITY INDEX F5Q3 202245.3%
VANGUARD INDEX FDS4Q4 202136.4%

View Summit Rock Advisors, LP's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-01-26
13F-HR2023-10-24
13F-HR2023-07-21
13F-HR2023-05-09
13F-HR2023-01-12
13F-HR2022-11-02
13F-HR2022-08-01
13F-HR2022-05-06
13F-HR2022-02-14
13F-HR2021-10-26

View Summit Rock Advisors, LP's complete filings history.

Compare quarters

Export Summit Rock Advisors, LP's holdings